“Stage 4 lupus” refers to Class IV lupus nephritis, the most severe and most common form of kidney involvement caused by systemic lupus erythematosus. It isn’t a stage of lupus itself but rather a classification of kidney damage, graded from Class I (mildest) to Class VI (most advanced scarring). Class IV means that more than 50% of the kidney’s filtering units, called glomeruli, are inflamed and damaged. It’s the form most likely to threaten long-term kidney function, but with aggressive treatment, many people stabilize or improve.
Why It’s Called “Class IV,” Not “Stage 4”
Lupus as a whole disease doesn’t have numbered stages the way cancer does. What does get classified is the kidney damage lupus can cause. The International Society of Nephrology and the Renal Pathology Society published a standardized system in 2003 that divides lupus nephritis into six classes based on what a kidney biopsy shows under a microscope. Class IV, often called diffuse proliferative lupus nephritis, is diagnosed when inflammation affects more than half of all glomeruli in the biopsy sample.
Within Class IV, doctors further subdivide the damage. If the inflammation hits only segments of each affected glomerulus, it’s labeled IV-S (segmental). If it spans the entire glomerulus, it’s IV-G (global). The biopsy report also notes whether the damage is mostly active inflammation (A), a mix of active and chronic scarring (A/C), or predominantly chronic scarring (C). These distinctions matter because active inflammation can respond to treatment, while chronic scarring generally cannot be reversed.
What Happens Inside the Kidneys
In Class IV lupus nephritis, the immune system deposits clumps of antibodies along the walls of the tiny blood vessels inside the glomeruli. These deposits settle beneath the inner lining of the capillary walls, triggering intense inflammation. Under a microscope, pathologists see characteristic “wire-loop” lesions, thick glassy rings formed by massive immune deposits pushing against the vessel walls. They may also see “hyaline thrombi,” round plugs of deposited material clogging capillary openings.
White blood cells flood into the capillary loops, making the glomeruli swollen and hypercellular. Over time, if the inflammation isn’t controlled, the basement membrane (the structural scaffold of the filtering unit) starts to duplicate and thicken. The surrounding tissue, including the tubes that carry filtered urine and the space between them, can also become inflamed. This widespread damage is what makes Class IV the most aggressive form of lupus nephritis.
Symptoms and Warning Signs
Many people with early lupus nephritis have no obvious kidney symptoms at all, which is why routine urine and blood tests are so important for anyone with lupus. As Class IV disease develops, the signs become more noticeable:
- Foamy urine, caused by protein leaking through damaged filters
- Swelling in the legs, ankles, or around the eyes, from fluid retention due to protein loss or high blood pressure
- High blood pressure, sometimes resistant to typical medications, with symptoms like headaches, dizziness, or visual changes
- Urinating more often or waking at night to urinate
- Blood in the urine, usually microscopic (visible only on a lab test) rather than visibly red
In more severe cases, fluid can accumulate in the abdomen or around the heart and lungs. Because Class IV involves such widespread glomerular damage, heavy protein loss in the urine is common, and kidney function can decline rapidly if treatment is delayed.
How It’s Diagnosed
A kidney biopsy is the only way to confirm Class IV lupus nephritis. No blood test or imaging study can distinguish it from the other classes. Doctors typically recommend a biopsy when urine tests show significant protein (above roughly 500 mg per day), when microscopic blood or red blood cell casts appear in the urine, or when a blood test measuring kidney filtration rate (eGFR) drops below expected levels.
The eGFR number estimates how well your kidneys are filtering waste. A normal value is above 90. Values between 60 and 90 suggest mild loss, while anything below 60 signals moderate kidney disease. In Class IV lupus nephritis, the eGFR can fall quickly during an active flare, making repeated monitoring essential even after treatment begins. Research has shown that even patients whose protein levels return to normal can continue losing kidney function over time, so doctors track the rate of eGFR decline rather than relying on a single number.
Prognosis and Kidney Failure Risk
Class IV lupus nephritis carries the highest risk of progressing to end-stage kidney failure among all the lupus nephritis classes. In studies from developed countries between 2000 and 2006, roughly 19% of people with Class IV disease reached end-stage kidney failure within five years. At ten years, that figure rose to about 33%, and at fifteen years to 44%. These numbers represent a significant improvement over earlier decades. In the 1970s, the five-year risk for lupus nephritis overall was around 16%, and it gradually dropped to about 11% by the mid-1990s as treatments improved.
The prognosis depends heavily on how much of the damage is active inflammation versus permanent scarring at the time of biopsy. People diagnosed early, before extensive scarring has set in, tend to respond better to treatment. Achieving what doctors call a “complete renal response,” meaning protein in the urine drops below 500 mg per day within the first one to two years of treatment, is strongly linked to better long-term kidney survival.
Treatment Approaches
Class IV lupus nephritis requires aggressive immune-suppressing treatment. The goal is to shut down the inflammatory attack on the kidneys quickly enough to prevent irreversible scarring. Treatment typically unfolds in two phases: an initial “induction” phase lasting several months to get the disease under control, followed by a longer “maintenance” phase that can last years to prevent flares.
In recent years, newer targeted therapies have been approved that improve outcomes beyond what older regimens achieve alone. Clinical trials involving over 1,200 patients have shown that two newer medications, one that calms overactive immune signaling in B cells and another that suppresses the immune response more precisely within the kidney, significantly increase the rate of complete kidney remission compared to standard therapy alone. These treatments are now used alongside traditional immune-suppressing drugs rather than replacing them. Your treatment plan will depend on the severity of your biopsy findings, your kidney function at diagnosis, and how you respond in the first several months.
Managing Daily Life With Class IV Lupus Nephritis
Beyond medications, managing blood pressure and protecting remaining kidney function are daily priorities. Because high blood pressure both results from and worsens kidney damage, keeping it controlled is one of the most impactful things you can do. Sodium intake plays a direct role. The National Kidney Foundation recommends that people with kidney disease or high blood pressure aim for no more than 1,500 mg of sodium per day, well below the general guideline of 2,300 mg. Reading labels carefully matters: products labeled “reduced sodium” still contain 75% of the original sodium, while “very low sodium” means under 35 mg per serving.
Fluid retention, fatigue, and joint pain from lupus itself can make physical activity feel difficult, but gentle movement helps manage blood pressure and overall well-being. Monitoring your weight daily can also help you spot fluid retention early, before visible swelling develops. Keeping all follow-up appointments for blood and urine tests is critical, since kidney function can shift between visits even when you feel stable. The goal of long-term management is not just remission but sustained kidney preservation, because even after inflammation quiets, slow ongoing damage can accumulate without obvious symptoms.